TH470

N/A

Report date: 2022/09/23 15:46:31
NME

Base Information

Drug NameTH470
Drug Alias NameTH-470
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLIM domain kinase 2 inhibitorsLIM domain kinase 1 inhibitors
TargetsLIM domain kinase 2LIM domain kinase 1
Therapy Area/IndicationsFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGoethe University Frankfurt
China Registration ClassN/A

Develop Information

Active CompaniesGoethe University Frankfurt
Inactive CompaniesN/A
Active IndicationsFragile X Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A